| # | Drug | Count |
|---|---|---|
| 0 | INFLIXIMAB | 50 |
| 1 | ADALIMUMAB | 49 |
| 2 | METHOTREXATE SODIUM | 48 |
| 3 | ETANERCEPT | 47 |
| 4 | PREDNISONE | 46 |
| 5 | LEFLUNOMIDE | 45 |
| 6 | PREGABALIN | 45 |
| 7 | TOCILIZUMAB | 45 |
| 8 | RITUXIMAB | 38 |
| 9 | METHOTREXATE | 37 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NADOFARAGENE FIRADENOVEC-VNCG | 4 | 0.0076 |
| 1 | TETRACAINE HYDROCHLORIDE | 1 | 0.0075 |
| 2 | SERTACONAZOLE NITRATE | 1 | 0.0062 |
| 3 | GOLD | 31 | 0.0053 |
| 4 | ACETIC ACID | 1 | 0.0028 |
| 5 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 6 | GATIFLOXACIN | 1 | 0.0006 |
| 7 | TAPINAROF | 1 | 0.0005 |
| 8 | SULFASALAZINE | 36 | 0.0005 |
| 9 | LEFLUNOMIDE | 45 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 1 | 0.0005 |
| 1 | Antirheumatic Agent [EPC] | 45 | 0.0004 |
| 2 | Aminosalicylate [EPC] | 36 | 0.0004 |
| 3 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 45 | 0.0003 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 5 | 0.0003 |
| 6 | Bismuth [EPC] | 1 | 0.0002 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 39 | 0.0001 |
| 8 | Quinolone Antimicrobial [EPC] | 1 | 0.0001 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 37 | 0.0001 |